Overview Fundamentals API Earnings EOD API Sample Code Pricing

Biocardia Inc (BCDA NASDAQ) stock market data APIs

$3.33 0.18(5.7%) as of July 16, 2024
Price chart is built with Anychart

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. Its lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. The company is also developing an allogeneic cells therapy platform, which is an investigational culture expanded bone marrow derived mesenchymal cell therapy in Phase I/II trial to treat ischemic heart failure and acute respiratory distress syndrome. In addition, it offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; and Morph deflectable guides and sheaths. The company has collaboration agreements with CellProthera in the development of ProtheraCytes, which is currently under Phase II trial for the treatment of acute myocardial infarction. BioCardia, Inc. is based in Sunnyvale, California.

Biocardia Inc Financial Data Overview

5 653 K
1 826 K
468 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BCDA',
Type: 'Common Stock',
Name: 'Biocardia Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000BTJTF3',
CIK: '925741',
EmployerIdNumber: '23-2753988',
FiscalYearEnd: 'December',
IPODate: '2008-03-14',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,

Biocardia Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 468 K
  • EBITDA -10 328 000
  • Earnings Per Share -7.05
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Biocardia Inc Earnings via APIs

  • Latest Release 2024-05-14
  • EPS/Forecast -0.2

Get Biocardia Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?